[go: up one dir, main page]

WO2010087964A3 - Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof - Google Patents

Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof Download PDF

Info

Publication number
WO2010087964A3
WO2010087964A3 PCT/US2010/000236 US2010000236W WO2010087964A3 WO 2010087964 A3 WO2010087964 A3 WO 2010087964A3 US 2010000236 W US2010000236 W US 2010000236W WO 2010087964 A3 WO2010087964 A3 WO 2010087964A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
acne
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2010/000236
Other languages
French (fr)
Other versions
WO2010087964A2 (en
Inventor
Joyce A. Sutcliffe
Susan M. Ciotti
James R. Baker, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanobio Corp
Original Assignee
Nanobio Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobio Corp filed Critical Nanobio Corp
Priority to CA2750233A priority Critical patent/CA2750233A1/en
Priority to EP10703377A priority patent/EP2391342A2/en
Publication of WO2010087964A2 publication Critical patent/WO2010087964A2/en
Publication of WO2010087964A3 publication Critical patent/WO2010087964A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to methods for treating and preventing acne or P. acnes infection in a subject comprising topically administering to the subject in need thereof an anti-acne nanoemulsion composition.
PCT/US2010/000236 2009-01-28 2010-01-28 Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof Ceased WO2010087964A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA2750233A CA2750233A1 (en) 2009-01-28 2010-01-28 Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
EP10703377A EP2391342A2 (en) 2009-01-28 2010-01-28 Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14796009P 2009-01-28 2009-01-28
US61/147,960 2009-01-28

Publications (2)

Publication Number Publication Date
WO2010087964A2 WO2010087964A2 (en) 2010-08-05
WO2010087964A3 true WO2010087964A3 (en) 2011-06-16

Family

ID=42077664

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/000236 Ceased WO2010087964A2 (en) 2009-01-28 2010-01-28 Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof

Country Status (4)

Country Link
US (1) US20100226983A1 (en)
EP (1) EP2391342A2 (en)
CA (1) CA2750233A1 (en)
WO (1) WO2010087964A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CA2671447A1 (en) 2006-12-01 2008-06-12 Anterios, Inc. Amphiphilic entity nanoparticles
EP2091516A2 (en) 2006-12-01 2009-08-26 Anterios, Inc. Peptide nanoparticles and uses therefor
US10016451B2 (en) 2007-05-31 2018-07-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
US9814422B2 (en) 2007-08-06 2017-11-14 The Regents Of The University Of California Compositions for solubilizing cells and/or tissue
US20110082216A1 (en) * 2009-10-02 2011-04-07 Wu Jeffrey M Benzoyl peroxide composition for treating skin
BR112013018919A2 (en) * 2011-01-24 2016-10-04 Anteriors Inc empty nanoparticle compositions and their use to treat dermatological problems
CN102166270A (en) * 2011-04-06 2011-08-31 西北农林科技大学 Oil-in-water type dried orange peel oil nano-emulsion and preparation method thereof
SE1300709A1 (en) * 2013-11-14 2015-05-15 Lipidor Ab Composition and method of topical treatment
US10206996B2 (en) 2011-08-22 2019-02-19 Nanobio Corporation Herpes simplex virus nanoemulsion vaccine
EP2753354A4 (en) 2011-09-09 2015-04-15 Nanobio Corp SUBUNIT VACCINE AGAINST NANOEMULSION SYNCYTIAL RESPIRATORY VIRUS (RSV)
RU2014111981A (en) * 2011-10-05 2015-11-10 Дуглас Фармасьютикалс Лтд. PHARMACEUTICAL METHODS AND COMPOSITIONS FOR LOCAL USE CONTAINING ACITRETINE
CN102526163A (en) * 2011-12-27 2012-07-04 浙江景岳堂药业有限公司 Method for extracting Olibanum and Myrrha in Fengtongling medicament
US20130224268A1 (en) * 2012-02-27 2013-08-29 Newgen Biopharma Corp. Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same
IN2014MN02536A (en) * 2012-05-16 2015-09-04 Univ California
US20130337095A1 (en) * 2012-06-18 2013-12-19 Waikatolink Limited Antimicrobial composition and its method of use
GB2503235A (en) * 2012-06-20 2013-12-25 Quest Vitamins Ltd Synergistic composition for minimising bacterial infection in animals
WO2014160279A1 (en) 2013-03-13 2014-10-02 Viroxis Corporation Stabilized cream formulations comprising sandalwood oil
GB201313803D0 (en) * 2013-08-01 2013-09-18 Omex Agriculture Ltd Fungicidal composition and method
DE102014102400A1 (en) * 2014-02-25 2015-08-27 Reinhard Caliebe Topical cosmetic or pharmaceutical composition
CN104738032B (en) * 2015-02-12 2017-03-08 河南科技学院 A kind of chlorocresol nano-emulsion disinfectant and preparation method thereof
KR102132543B1 (en) * 2015-06-19 2020-07-09 글로벌 헬스 솔루션즈, 엘엘씨 Petrolatum-based composition comprising cationic biocide
US12290599B2 (en) 2015-06-19 2025-05-06 Global Health Solutions Llc Oil-based wound care compositions and methods
KR20170003414A (en) * 2015-06-30 2017-01-09 (주)아모레퍼시픽 Fast soluble type granule pill composition for hair washing
EP3328359A4 (en) * 2015-07-31 2019-03-27 NanoBio Corporation Methods of treating acne using nanoemulsion compositions
US10857191B2 (en) 2015-10-07 2020-12-08 Santalis Pharmaceuticals, Inc. Sandalwood oil and its uses related to oral mucositis
WO2018093465A1 (en) 2016-11-21 2018-05-24 Eirion Therapeutics, Inc. Transdermal delivery of large agents
RU2729079C1 (en) 2017-01-31 2020-08-04 Кимберли-Кларк Ворлдвайд, Инк. Antibacterial composition containing ester of benzoic acid, and methods for inhibiting bacterial growth by using thereof
CN111372565A (en) * 2017-09-26 2020-07-03 强生消费者公司 Topical compositions and methods for treating and preventing atopic dermatitis and infections associated with bacterial biofilms
US20210393554A1 (en) 2018-11-15 2021-12-23 Bluewillow Biologics, Inc. Nanoemulsion compositions having enhanced permeability
US11369578B2 (en) 2018-11-15 2022-06-28 Bluewillow Biologics, Inc. Persistent topical antimicrobial compositions and methods of using the same
CN109541118A (en) * 2018-12-27 2019-03-29 江苏艾兰得营养品有限公司 A kind of method that energy quicklook identifies needle juniper seed extract
WO2021022045A1 (en) 2019-07-31 2021-02-04 Ecolab Usa Inc. Personal protective equipment free delimer compositions
WO2021087051A1 (en) * 2019-10-30 2021-05-06 Ps Therapy Ltd. Topical compositions and methods of use thereof
WO2021222428A1 (en) * 2020-04-29 2021-11-04 Kao Corporation Self‑tanning compositions containing an alkyl sulfonate and methods thereof
CN114099440B (en) * 2021-12-08 2023-06-13 中国药科大学 A transfersome topical drug delivery system loaded with hydrophobic antioxidant drugs
EP4547213A1 (en) * 2022-06-29 2025-05-07 Unilever IP Holdings B.V. Anti-acne composition

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549901A (en) * 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
US20020119207A1 (en) * 1999-04-28 2002-08-29 The Regent Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20070243132A1 (en) * 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
WO2009158687A1 (en) * 2008-06-26 2009-12-30 Anterios, Inc. Dermal delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4895452A (en) * 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5103497A (en) * 1989-11-14 1992-04-07 Hicks John W Flying spot endoscope
WO1991010418A1 (en) * 1990-01-19 1991-07-25 Shiseido Company, Ltd. Dermatologic preparation
JP2937667B2 (en) * 1992-11-19 1999-08-23 高砂香料工業株式会社 Skin external preparation for acne vulgaris
US6015832A (en) 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US6559189B2 (en) 1999-04-28 2003-05-06 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
AU781563B2 (en) 2000-02-02 2005-06-02 Warner-Lambert Company Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders
WO2004030608A2 (en) * 2001-06-05 2004-04-15 The Regents Of The University Of Michigan Nanoemulsion vaccines
WO2005030172A1 (en) 2003-09-24 2005-04-07 The Regents Of The University And Methods Antimicrobial nanoemulsion compositions and methods
WO2006110699A1 (en) 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
EP1951200A2 (en) 2005-08-09 2008-08-06 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549901A (en) * 1994-05-20 1996-08-27 Novavax, Inc. Antimicrobial oil-in-water emulsions
US20020119207A1 (en) * 1999-04-28 2002-08-29 The Regent Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US20070243132A1 (en) * 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
WO2009158687A1 (en) * 2008-06-26 2009-12-30 Anterios, Inc. Dermal delivery

Also Published As

Publication number Publication date
WO2010087964A2 (en) 2010-08-05
CA2750233A1 (en) 2010-08-05
EP2391342A2 (en) 2011-12-07
US20100226983A1 (en) 2010-09-09

Similar Documents

Publication Publication Date Title
WO2010087964A3 (en) Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
WO2009089494A3 (en) Pharmaceutical compositions
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2012092336A3 (en) Molecular profiling for cancer
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
MX2011009539A (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof.
WO2012170807A3 (en) Anti-pseudomonas psl binding molecules and uses thereof
WO2009039337A3 (en) Inhibition of angiogenesis
HK1210962A1 (en) Methods for treatment of atherosclerosis
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
WO2012012278A3 (en) Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
WO2010088450A3 (en) Arylamide derivatives useful in the treatment of diseases associated with serca activity
WO2010032011A3 (en) Anti-fungal therapy
WO2011042902A3 (en) Microcapsules comprising benzoyl peroxide and topical compositions comprising them
UA107687C2 (en) A combined composition comprising as active ingredients l-carnitine or propionyl l-carnitine, troxerutine, diosmlne and hesperidine, for the prevention and/or treatment of chronic venous diseases
WO2009090394A3 (en) Composition containing capsicum for treating a skin disorder
HK1223632A1 (en) Targeted enzyme compounds and uses thereof
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
WO2010021750A3 (en) Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
WO2009155070A3 (en) Compositions and methods for treatment of inflammation and hyperkeratotic lesions
WO2012078586A3 (en) Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer
WO2013000895A9 (en) Dha and epa in the reduction of oxidative stress
WO2010042212A3 (en) Methods for treating or preventing pain using spicamycin derivatives

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10703377

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2750233

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010703377

Country of ref document: EP